Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer
- 4 October 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (45) , 6632-6637
- https://doi.org/10.1038/sj.onc.1204727
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 30 references indexed in Scilit:
- Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic MutationsScience, 2000
- Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patientsEuropean Journal Of Cancer, 1999
- A novel adenoviral vector expressing human Fas/CD95/APO-1 enhances p53-mediated apoptosisCell Death & Differentiation, 1999
- Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lungEuropean Respiratory Journal, 1998
- Apoptosis by Death FactorCell, 1997
- Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune EscapeScience, 1996
- Expression of the Fas antigen on primary human leukemia cellsAnnals of Hematology, 1995
- The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19Genomics, 1992
- Definition of a consensus binding site for p53Nature Genetics, 1992
- A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.The Journal of Experimental Medicine, 1989